一 |
六届全明星德罗赞以一年390万美元底薪加盟丹佛掘金后，掘金随队记者Harrison Wind在节目中称赞了这笔操作。他认为，德罗赞的加入将直接解决球队替补席进攻乏力的问题。 CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。
Wind表示：“我之前对球队的替补席真是捏了一把汗，他们毫无得分能力。但现在，他们拥有了德罗赞。这是一笔很棒的运作。虽然我讨厌球队放走沃特森的决定，但得到德罗赞对掘金来说非常关键。德罗赞可以充当第二阵容的领袖，他的加盟能帮球队做很多事情。”
德罗赞上赛季场均贡献18.4分、2.9个篮板和4.1次助攻，保持了稳定的得分效率。掘金今夏流失了沃特森（4年8800万先签后换加盟骑士），替补阵容深度受到削弱。
二 | 德罗赞的加盟被外界视为一次精准的补强，他不仅能在约基奇下场时承担持球进攻任务，也为掘金在季后赛中提供了除穆雷之外的第二位经验丰富的关键球处理者。
德罗赞此前在国王队的合同原为2570万美元，但在被裁后以老将底薪加盟掘金，这也使他成为掘金历史上签约过的最具资历的自由球员之一。掘金管理层和教练组在招募过程中向德罗赞展示了他在进攻体系中扮演的核心角色，并最终说服了这位37岁的老将以底薪加入争冠团队。
Current article:http://9t4n.foujiongwenruapoumeizhan.buzz/nakftw6/20260826/6135.html
Published on:21:20:49
